Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Randomization-based analysis of covariance for inference in the sequential parallel comparison design.

Wiener LE, Ivanova A, Li S, Silverman RK, Koch GG.

J Biopharm Stat. 2019;29(4):696-713. doi: 10.1080/10543406.2019.1633660. Epub 2019 Jul 15.

PMID:
31304861
2.

Sexually Transmitted Disease Partner Services Costs, Other Resources, and Strategies Across Jurisdictions to Address Unique Epidemic Characteristics and Increased Incidence.

Silverman RA, Katz DA, Levin C, Bell TR, Spellman D, St John L, Manley Rodriguez E, Golden MR, Barnabas RV.

Sex Transm Dis. 2019 Aug;46(8):493-501. doi: 10.1097/OLQ.0000000000001010.

PMID:
31295215
3.

Minority and majority pretreatment HIV-1 drug resistance associated with failure of first-line nonnucleoside reverse-transcriptase inhibitor antiretroviral therapy in Kenyan women.

Milne RS, Silverman RA, Beck IA, Mckernan-Mullin J, Deng W, Sibley TR, Dross S, Kiarie JN, Sakr SR, Coombs RW, Chung MH, Frenkel LM.

AIDS. 2019 May 1;33(6):941-951. doi: 10.1097/QAD.0000000000002134.

PMID:
30946148
4.

On results reporting and evidentiary standards: spotlight on the Global Fund.

Friebel R, Silverman R, Glassman A, Chalkidou K.

Lancet. 2019 May 11;393(10184):2006-2008. doi: 10.1016/S0140-6736(18)33055-1. Epub 2019 Jan 25. No abstract available.

PMID:
30691700
5.

Minority and majority pre-treatment HIV-1 drug resistance associated with failure of 1st-line NNRTI ART in Kenyan women.

Milne RS, Silverman RA, Beck IA, Mckernan-Mullin J, Deng W, Sibley TR, Dross S, Kiarie JN, Sakr SR, Coombs RW, Chung MH, Frenkel LM.

AIDS. 2019 Jan 16. doi: 10.1097/QAD.0000000000002134. [Epub ahead of print]

PMID:
30664004
6.

Sequential parallel comparison design with binary and time-to-event outcomes.

Silverman RK, Ivanova A, Fine J.

Stat Med. 2018 Apr 30;37(9):1454-1466. doi: 10.1002/sim.7635. Epub 2018 Feb 20.

PMID:
29462838
7.

Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013-2014.

Silverman RA, Beck IA, Kiptinness C, Levine M, Milne R, McGrath CJ, Bii S, Richardson BA, John-Stewart G, Chohan B, Sakr SR, Kiarie JN, Frenkel LM, Chung MH.

J Infect Dis. 2017 Dec 19;216(12):1569-1578. doi: 10.1093/infdis/jix544.

8.

New prostate cancer prognostic grade group (PGG): Can multiparametric MRI (mpMRI) accurately separate patients with low-, intermediate-, and high-grade cancer?

Holtz JN, Silverman RK, Tay KJ, Browning JT, Huang J, Polascik TJ, Gupta RT.

Abdom Radiol (NY). 2018 Mar;43(3):702-712. doi: 10.1007/s00261-017-1255-8.

PMID:
28721479
9.

My femme friendship.

Silverman RE.

J Lesbian Stud. 2018 Jan 2;22(1):85-93. doi: 10.1080/10894160.2017.1295759. Epub 2017 Mar 20.

PMID:
28318432
10.

Persistence of HIV drug resistance among South African children given nevirapine to prevent mother-to-child-transmission.

Kanthula R, Rossouw TM, Feucht UD, van Dyk G, Beck IA, Silverman R, Olson S, Salyer C, Cassol S, Frenkel LM.

AIDS. 2017 May 15;31(8):1143-1148. doi: 10.1097/QAD.0000000000001446.

11.

Platform-Independent Cirrus and Spectralis Thickness Measurements in Eyes with Diabetic Macular Edema Using Fully Automated Software.

Willoughby AS, Chiu SJ, Silverman RK, Farsiu S, Bailey C, Wiley HE, Ferris FL 3rd, Jaffe GJ.

Transl Vis Sci Technol. 2017 Feb 7;6(1):9. doi: 10.1167/tvst.6.1.9. eCollection 2017 Feb.

12.

Sample size re-estimation and other midcourse adjustments with sequential parallel comparison design.

Silverman RK, Ivanova A.

J Biopharm Stat. 2017;27(3):416-425. doi: 10.1080/10543406.2017.1289951. Epub 2017 Feb 6.

PMID:
28166457
13.

How to Get Cost-Effectiveness Analysis Right? The Case of Vaccine Economics in Latin America.

Glassman A, Cañón O, Silverman R.

Value Health. 2016 Dec;19(8):913-920. doi: 10.1016/j.jval.2016.04.014. Erratum in: Value Health. 2017 Mar;20(3):516.

14.

Can Radiologic Staging With Multiparametric MRI Enhance the Accuracy of the Partin Tables in Predicting Organ-Confined Prostate Cancer?

Gupta RT, Brown AF, Silverman RK, Tay KJ, Madden JF, George DJ, Polascik TJ.

AJR Am J Roentgenol. 2016 Jul;207(1):87-95. doi: 10.2214/AJR.15.15878. Epub 2016 Apr 11.

PMID:
27064383
15.

Increasing HIV-1 pretreatment drug resistance among antiretroviral-naïve adults initiating treatment between 2006 and 2014 in Nairobi, Kenya.

Chung MH, Silverman R, Beck IA, Yatich N, Dross S, McKernan-Mullin J, Bii S, Tapia K, Stern J, Chohan B, Sakr SR, Kiarie JN, Frenkel LM.

AIDS. 2016 Jun 19;30(10):1680-2. doi: 10.1097/QAD.0000000000001110.

16.

Steroid and anticonvulsant prophylaxis for stereotactic radiosurgery: Large variation in physician recommendations.

Arvold ND, Pinnell NE, Mahadevan A, Connelly S, Silverman R, Weiss SE, Kelly PJ, Alexander BM.

Pract Radiat Oncol. 2016 Jul-Aug;6(4):e89-96. doi: 10.1016/j.prro.2015.11.004. Epub 2015 Nov 10.

PMID:
26850650
17.

Defining the Incremental Utility of Prostate Multiparametric Magnetic Resonance Imaging at Standard and Specialized Read in Predicting Extracapsular Extension of Prostate Cancer.

Tay KJ, Gupta RT, Brown AF, Silverman RK, Polascik TJ.

Eur Urol. 2016 Aug;70(2):211-3. doi: 10.1016/j.eururo.2015.10.041. Epub 2015 Nov 6.

PMID:
26553331
18.

How a new funding model will shift allocations from the Global Fund to Fight AIDS, tuberculosis, and malaria.

Fan VY, Glassman A, Silverman RL.

Health Aff (Millwood). 2014 Dec;33(12):2238-46. doi: 10.1377/hlthaff.2014.0240. Epub 2014 Nov 12.

PMID:
25392001
19.

Performance-based financing at the Global Fund to Fight AIDS, Tuberculosis and Malaria: an analysis of grant ratings and funding, 2003-12.

Fan VY, Duran D, Silverman R, Glassman A.

Lancet Glob Health. 2013 Sep;1(3):e161-8. doi: 10.1016/S2214-109X(13)70017-2. Epub 2013 Aug 23.

20.

The efficacy of interventions to reduce adolescent childbearing in low- and middle-income countries: a systematic review.

McQueston K, Silverman R, Glassman A.

Stud Fam Plann. 2013 Dec;44(4):369-88. doi: 10.1111/j.1728-4465.2013.00365.x. Review.

PMID:
24323658

Supplemental Content

Loading ...
Support Center